The Future of Atrial Fibrillation Care, From Innovation to Implementation

A Keck Medicine of USC cardiac electrophysiologist discusses 3 takeaways about the future of atrial fibrillation treatment.

1

Pulsed field ablation has become an established option, but complex arrhythmias may require a customized strategy combining pulsed field and radiofrequency energy.
2

Evidence and newer guidelines support earlier ablation referral; referral within 6 months of diagnosis is ideal, and referral within 12 months remains beneficial.
3

Ablation is not a cure, but it can reduce atrial fibrillation burden, slow disease progression, and improve quality of life.
4

Anticoagulation decisions are currently based on stroke risk factors rather than rhythm status alone, so successful ablation does not necessarily mean patients can stop blood thinners.
5

The enrolling REACT-AF trial is testing whether smartwatch-guided anticoagulation can safely replace continuous treatment with use during detected atrial fibrillation periods.

1